Condition
Recurrent clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Recurrent clinical trials that are recruiting, at sites in 3 countries (most in United States (3), Italy (1), India (1)). By phase: Phase 1 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Recurrent clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Outcomes for Oligometastatic and Oligorecurrent Cervical Cancer | — | Mumbai, Maharashtra | Recruiting | Feb 10, 2026 |
| How exercise relates to health and cancer outcomes in adult survivors | — | Los Angeles, California and 2 other locations | Recruiting | Jun 22, 2025 |
| Using modified T cells to treat recurrent ovarian cancer | Phase 1 | Chapel Hill, North Carolina | Recruiting | Mar 12, 2024 |
| Using modified T cells to treat relapsed head and neck cancer | Phase 1 | Chapel Hill, North Carolina | Recruiting | Oct 23, 2023 |
| Re-irradiation for women with recurrent breast cancer after previous treatment | Phase 2 | Meldola, Forlì Cesena | Recruiting | Mar 16, 2023 |
All recruiting trials (5)
-
Outcomes for Oligometastatic and Oligorecurrent Cervical Cancer
This registry will see if adding local treatments such as radiation or surgery to standard systemic therapy helps people with oligo‑metastatic or oligo‑recurrent cervical cancer live longer or avoid progression.
-
How exercise relates to health and cancer outcomes in adult survivors
This project will see if exercising after treatment is linked to cancer outcomes and other health events in adults who have finished primary cancer therapy.
-
Using modified T cells to treat recurrent ovarian cancer
This study is testing a new treatment using modified immune cells to see if it can help people with recurrent ovarian cancer that hasn't responded to standard treatments.
-
Using modified T cells to treat relapsed head and neck cancer
This study is testing a new treatment using modified immune cells to see if it can help people with relapsed head and neck cancer feel better and improve their outcomes.
-
Re-irradiation for women with recurrent breast cancer after previous treatment
This study is testing a new way to treat women with recurring breast cancer by using targeted radiation again to see if it can help them keep their breast instead of needing surgery.
Related topics
Quick answers
How many Recurrent clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), Italy (1 trial), India (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.